Malignancy and Cardiovascular Risk Assessment Using the Consortium of Rheumatology Researchers of North America Registry (Corrona) as an External Comparator for Tofacitinib-Exposed Patients within the Rheumatoid Arthritis BID Clinical Trial Program: A Comparative Post-Approval Safety Study (Matched Analysis for Xeljanz with Corrona)

Documents

Study protocol

Initial protocol

A3921204_PROTOCOL_Final_9Nov2017

Updated protocol

A3921204_PROTOCOL and APPROVAL AMENDMENT 3_18May2020_

First published: 22/02/2024

Study results

Study results

CT24-WI-GL15-RF01 1.0 NI Study Report Abstract 09 March 2021

Study report

Study report

CT24-WI-GL15-RF02 2.0 NI Study Report 09 March 2021 (1)

Other information

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

Conflicts of interest of investigators

DoI_EUPAS23344